{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:27:08Z","timestamp":1791041228629,"version":"4.1.0"},"reference-count":40,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,5,30]]},"DOI":"10.3233\/jad-180243","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T10:40:35Z","timestamp":1526640035000},"page":"1395-1404","source":"Crossref","is-referenced-by-count":46,"title":["Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer\u2019s Disease Patients"],"prefix":"10.1177","volume":"63","author":[{"given":"Montserrat","family":"Costa","sequence":"first","affiliation":[{"name":"Grifols Bioscience Research Group, Grifols, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Horrillo","sequence":"additional","affiliation":[{"name":"Grifols Bioscience Research Group, Grifols, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Ortiz","sequence":"additional","affiliation":[{"name":"Grifols Bioscience Research Group, Grifols, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"P\u00e9rez","sequence":"additional","affiliation":[{"name":"Grifols Bioscience Research Group, Grifols, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mestre","sequence":"additional","affiliation":[{"name":"Grifols Bioscience Research Group, Grifols, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Ruiz","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic, Fundaci\u00f3 ACE, Institut Catal\u00e0 de Neuroci\u00e8nces Aplicades-Universitat Internacional de Catalunya, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Boada","sequence":"additional","affiliation":[{"name":"Research Center and Memory Clinic, Fundaci\u00f3 ACE, Institut Catal\u00e0 de Neuroci\u00e8nces Aplicades-Universitat Internacional de Catalunya, Barcelona, Spain"},{"name":"Department of Neurology, Hospital General Universitari Vall d\u2019Hebr\u00f3n, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Grancha","sequence":"additional","affiliation":[{"name":"Grifols Bioscience Research Group, Grifols, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-180243_ref1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-2009-1158","article-title":"Neuropathology and the neuroinflammation idea","volume":"18","author":"Mrak","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180243_ref2","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1371\/journal.pone.0000536","article-title":"Mitochondrial oxidative stress causes hyperphosphorylation of tau","volume":"2","author":"Melov","year":"2007","journal-title":"PLoS One"},{"key":"10.3233\/JAD-180243_ref3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-180243_ref4","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.bbapap.2011.10.001","article-title":"Circulating biomarkers of protein oxidation for Alzheimer disease: Expectations within limits","volume":"1814","author":"Di Domenico","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-180243_ref5","doi-asserted-by":"crossref","first-page":"316523","DOI":"10.1155\/2013\/316523","article-title":"Oxidative stress and the pathogenesis of Alzheimer\u2019s disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.3233\/JAD-180243_ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2015.12.004","article-title":"Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients","volume":"91","author":"Di Domenico","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-180243_ref7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000256209","article-title":"Increase in the oxidized\/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer\u2019s disease patients","volume":"28","author":"Isobe","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-180243_ref8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/ggi.12361","article-title":"Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer\u2019s disease","volume":"15","author":"Altunoglu","year":"2015","journal-title":"Geriatr Gerontol Int"},{"key":"10.3233\/JAD-180243_ref9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/10715760802255764","article-title":"Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer\u2019s disease","volume":"42","author":"Greilberger","year":"2008","journal-title":"Free Radic Res"},{"key":"10.3233\/JAD-180243_ref10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.exger.2012.05.019","article-title":"Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia","volume":"47","author":"Puertas","year":"2012","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-180243_ref11","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1089\/ars.2012.4702","article-title":"Redox albuminomics: Oxidized albumin in human diseases","volume":"17","author":"Colombo","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.3233\/JAD-180243_ref12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/bbrc.1996.0793","volume":"222","author":"Cha","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-180243_ref13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s10384-010-0877-y","article-title":"Difference in redox status of serum and aqueous humor in senile cataract patients as monitored via the albumin thiol-redox state","volume":"54","author":"Kawai","year":"2010","journal-title":"Jpn J Ophthalmol"},{"key":"10.3233\/JAD-180243_ref14","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","volume":"58","author":"Garcia-Martinez","year":"2013","journal-title":"Hepatology"},{"key":"10.3233\/JAD-180243_ref15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/JAD-160565","article-title":"Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-beta concentrations and cognition outcomes in Alzheimer\u2019s disease patients: A multicenter, randomized, controlled clinical trial","volume":"56","author":"Boada","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180243_ref16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-170693","article-title":"Longitudinal neuroimaging analysis in mild-moderate Alzheimer\u2019s disease patients treated with plasma exchange with 5% human albumin","volume":"61","author":"Cuberas-Borr\u00f3s","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180243_ref17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000051268","article-title":"The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer\u2019s disease, reflecting a common pathophysiological process","volume":"12","author":"Sjogren","year":"2001","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-180243_ref18","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"key":"10.3233\/JAD-180243_ref19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: A consensus report","volume":"57","author":"Andersson","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-180243_ref20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000116919","article-title":"Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age","volume":"33","author":"Blennow","year":"1993","journal-title":"Eur Neurol"},{"key":"10.3233\/JAD-180243_ref21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365517709091496","article-title":"Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values","volume":"37","author":"Tibbling","year":"1977","journal-title":"Scand J Clin Lab Invest"},{"key":"10.3233\/JAD-180243_ref22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0076-6879(10)74011-8","article-title":"Redox state of human serum albumin in terms of cysteine-34 in health and disease","volume":"474","author":"Oettl","year":"2010","journal-title":"Methods Enzymol"},{"key":"10.3233\/JAD-180243_ref23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1159\/000082524","article-title":"Alteration of redox state of human serum albumin before and after hemodialysis","volume":"22","author":"Soejima","year":"2004","journal-title":"Blood Purif"},{"key":"10.3233\/JAD-180243_ref24","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1111\/j.1742-4658.2006.05341.x","article-title":"Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions","volume":"273","author":"Kawakami","year":"2006","journal-title":"FEBS J"},{"key":"10.3233\/JAD-180243_ref25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1255\/ejms.1256","article-title":"A fast and validated mass spectrometry method for the evaluation of human serum albumin structural modifications in the clinical field","volume":"19","author":"Naldi","year":"2013","journal-title":"Eur J Mass Spectrom (Chichester)"},{"key":"10.3233\/JAD-180243_ref26","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.27322","volume":"60","author":"Domenicali","year":"2014","journal-title":"Hepatology"},{"key":"10.3233\/JAD-180243_ref27","unstructured":"Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences, Lawrence Erlbaum Associates, Hillsdale, N.J."},{"key":"10.3233\/JAD-180243_ref28","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/pmic.200500285","article-title":"Differential post-translational modifications of transthyretin in Alzheimer\u2019s disease: A study of the cerebral spinal fluid","volume":"6","author":"Biroccio","year":"2006","journal-title":"Proteomics"},{"key":"10.3233\/JAD-180243_ref29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12576-009-0028-8","article-title":"Human astrocytes and aortic endothelial cells actively convert the oxidized form of albumin to the reduced form: Reduced albumin might participate in redox regulation of nerve and blood vessel systems","volume":"59","author":"Matsuyama","year":"2009","journal-title":"J\u00a0Physiol Sci"},{"key":"10.3233\/JAD-180243_ref30","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1468-1331.2011.03357.x","article-title":"Identification of oxidized serum albumin in the cerebrospinal fluid of ischaemic stroke patients","volume":"18","author":"Moon","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-180243_ref31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.bjp.0707251","article-title":"Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties","volume":"151","author":"Oettl","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JAD-180243_ref32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1744-9987.12024","article-title":"Human nonmercaptalbumin-2: A novel prognostic marker in chronic liver failure","volume":"18","author":"Stauber","year":"2014","journal-title":"Ther Apher Dial"},{"key":"10.3233\/JAD-180243_ref33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11064-007-9453-3","article-title":"Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias","volume":"33","author":"Casado","year":"2008","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-180243_ref34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.neurobiolaging.2005.01.001","article-title":"Oxidative imbalance in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"27","author":"Guidi","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-180243_ref35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-510X(97)00172-X","article-title":"Free radicals and superoxide dismutase in blood of patients with Alzheimer\u2019s disease and vascular dementia","volume":"153","author":"Ihara","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-180243_ref36","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/(SICI)1099-1166(1998120)13:12<840::AID-GPS877>3.0.CO;2-R","article-title":"Altered plasma antioxidant status in subjects with Alzheimer\u2019s disease and vascular dementia","volume":"13","author":"Sinclair","year":"1998","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-180243_ref37","volume-title":"Proteins of the Cerebrospinal Fluid: Analisys and interpretation in the Diagnosis and Treatment of Neurological Disease","author":"Thompson","year":"2005"},{"key":"10.3233\/JAD-180243_ref38","doi-asserted-by":"crossref","first-page":"e2829","DOI":"10.1371\/journal.pone.0002829","article-title":"Human microglial cells synthesize albumin in brain","volume":"3","author":"Ahn","year":"2008","journal-title":"PLoS One"},{"key":"10.3233\/JAD-180243_ref39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fphys.2014.00299","article-title":"Unraveling the mysteries of serum albumin-more than just a serum protein","volume":"5","author":"Merlot","year":"2014","journal-title":"Front Physiol"},{"key":"10.3233\/JAD-180243_ref40","doi-asserted-by":"crossref","first-page":"e0177799","DOI":"10.1371\/journal.pone.0177799","article-title":"In-vivo oxidized albumin- a pro-inflammatory agent in hypoalbuminemia","volume":"12","author":"Magzal","year":"2017","journal-title":"PLoS One"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-180243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:08Z","timestamp":1777370828000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-180243"}},"subtitle":[],"editor":[{"given":"Torbj\u00f6rn","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":40,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-180243","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,30]]}}}